Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.77	12.54	15.44
Graham Fair Price	17.67	5.04	4.29
PEG	362.10	0.40	-0.09
Price/Book	-10.27	1.55	1.72
Price/Cash Flow	-52.23	7.54	15.78
Prices/Earnings	-26.48	10.10	13.74
Price/Sales	16.31	1.70	1.46
Price/FCF	-52.23	7.54	15.78
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-78.44	0.06	0.30
Operating Margin	2.26	0.06	0.06
ROA	29.76	0.01	< 0.005
ROE	0.03	0.04	22.06
ROIC	0.02	0.02	-25.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.13	94.40
Dividends QOQ	< 0.005	-1.00	22440.00
EBIT QOQ	2.42	-0.17	-93.17
EPS QOQ	1.57	0.25	-84.09
FCF QOQ	9.30	0.99	-89.38
Revenue QOQ	0.24	-0.18	-24.97
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.69	2.12	-21.43
Days Sales Outstanding (DSO)	66.08	69.28	4.84
Inventory Turnover	33.40	42.50	27.27
Debt/Capitalization	0.56	0.54	-2.85
Quick Ratio	1.06	1.13	7.03
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.10	5.43	6.50
Cash	4.33	5.15	19.00
Capex	-0.24	-0.07	71.34
Free Cash Flow	0.56	1.11	100.08
Revenue	6.03	4.95	-17.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.13	1.17	4.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.96	1.39	-53.02
Naive Interpretation	Member

06 - Financial Health · Bad

Rating